EUVIMEDEUVIMED entdecken
Crossref

Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders

Irina A. Antonijevic, Brian R. Bettencourt, Peter Bialek, Pei Ge, Shi-Ying Ding, George Lai, Joseph Hedde, Eva Asp, Meetu Seth, George Marnellos, Katharine A. Whartenby, Darren G. Monckton und 1 weitere

GEN Biotechnology · 2022

DOI: 10.1089/genbio.2021.0012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GEN Biotechnology, 2022. Verfasst von Irina A. Antonijevic und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huntington disease (HD) is one of a growing number of rare genetic diseases characterized by the inheritance of an increased number of short tandem repeats within the affected gene. Many of these repeat expansion disorders (REDs) affect the brain. Although inheritance of the mutant allele is a necessary first step for disease manifestation, a second step of further expansion of the inherited expanded repeats, particularly in neurons in the brain, also appears to play a critical role toward disease manifestation. This dynamic process, called somatic expansion, is modulated by genes involved in the repair of DNA that operate upstream of the specific gene associated with each individual disease. As somatic expansion has been described in multiple REDs, genes associated with regulating somatic expansion are attractive therapeutic targets, since multiple REDs could potentially be treated with the same drug.

Zitieren

APA

Antonijevic, I. A., Bettencourt, B. R., Bialek, P., Ge, P., Ding, S., Lai, G., Hedde, J., Asp, E., Seth, M., Marnellos, G., Whartenby, K. A., Monckton, D. G., & Tabrizi, S. J. (2022). Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders. GEN Biotechnology. https://doi.org/10.1089/genbio.2021.0012

Vancouver

Antonijevic IA, Bettencourt BR, Bialek P, Ge P, Ding S, Lai G, et al. Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders. GEN Biotechnology. 2022. doi:10.1089/genbio.2021.0012

BibTeX
@article{Antonijevic2022,
  author = {Antonijevic, Irina A. and Bettencourt, Brian R. and Bialek, Peter and Ge, Pei and Ding, Shi-Ying and Lai, George and Hedde, Joseph and Asp, Eva and Seth, Meetu and Marnellos, George and Whartenby, Katharine A. and Monckton, Darren G. and Tabrizi, Sarah J.},
  title = {Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders},
  journal = {GEN Biotechnology},
  year = {2022},
  doi = {10.1089/genbio.2021.0012}
}
Kostenlos starten →